risperidone has been researched along with mdl 100907 in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (13.33) | 18.2507 |
| 2000's | 13 (43.33) | 29.6817 |
| 2010's | 11 (36.67) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, LJ; Hutson, PH; Rowley, M | 1 |
| Bonaventure, P; Carruthers, NI; Dvorak, CA; Dvorak, L; Lovenberg, TW; Miller, KL; Nepomuceno, D; Rudolph, DA; Shireman, BT | 1 |
| Giordanetto, F; Leach, AG; Zachariae, U | 1 |
| Brocco, M; Millan, MJ; Schreiber, R | 1 |
| Fischer, TR; Hitchcock, JM; Lister, S; Wettstein, JG | 1 |
| Bakshi, VP; Geyer, MA; Varty, GB | 1 |
| Alsayegh, L; Backstrom, JR; Berry, SA; Friedman, L; Roth, BL; Sanders-Bush, E; Willins, DL | 1 |
| Ichikawa, J; Meltzer, HY | 1 |
| Carlsson, A; Carlsson, ML; Nilsson, M; Waters, N; Waters, S | 1 |
| Honkanen, A; Huttunen, MO; Hyytiä, P; Ingman, K; Korpi, ER | 1 |
| Ikeda, M; Iwata, N; Kitajima, T; Ozaki, N; Suzuki, T; Yamanouchi, Y | 1 |
| Alevizos, B; Christodoulou, GN; Lykouras, L; Zervas, IM | 1 |
| De La Garza, R; Kalechstein, AD; Newton, TF | 1 |
| Jeong, JH; Kang, MS; Kim, DM; Kim, JS | 1 |
| Altschuler, EL; Focosi, D; Kast, RE; Petrini, M | 1 |
| Diamant, L; Gaisler-Salomon, I; Rubin, C; Weiner, I | 1 |
| Arnt, J; Mørk, A; Witten, LM | 1 |
| Choi, YK; Gardner, MP; Moran-Gates, T; Tarazi, FI | 1 |
| Adams, W; van den Buuse, M | 1 |
| Craig, F; Margari, F; Margari, L; Matera, E; Palmieri, VO; Pastore, A; Petruzzelli, MG | 1 |
| Fijał, K; Nikiforuk, A; Popik, P | 1 |
| Amodeo, DA; Jones, JH; Ragozzino, ME; Sweeney, JA | 1 |
| Chuluun, B; Colas, D; Das, D; Garner, CC; Heller, HC; Lin, B; Moghadam, S; Salehi, A | 1 |
| Guo, Y; Hu, L; Liu, C; Luo, B; Wang, H | 1 |
| Baki, L; Drossopoulos, P; Dukat, M; Ellaithy, A; Eltit, JM; Gaitonde, SA; Glennon, RA; González-Maeso, J; Hideshima, KS; Logothetis, DE; Moreno, JL; Shah, S; Vekariya, R; Younkin, J | 1 |
| Gu, F; Ma, W; Meng, G; Wang, Y; Wu, C | 1 |
| He, Y; Jiang, H; Jiang, X; Li, J; Liu, Y; Shen, J; Tian, G; Wang, Y; Wang, Z; Wu, C; Xu, M; Yang, F; Ye, B; Zhang, J; Zhao, Q | 1 |
| Alemany-González, M; Chanovas, J; Delgado-Sallent, C; Gener, T; Nebot, P; Puig, MV; Tauste Campo, A | 1 |
| Makiguchi, A; Okada, T; Shioda, K; Suda, S | 1 |
| Basu, B; John Jayakumar, JAK; Panicker, MM | 1 |
1 review(s) available for risperidone and mdl 100907
| Article | Year |
|---|---|
Current and novel approaches to the drug treatment of schizophrenia.
Topics: Animals; Antipsychotic Agents; Cholinergic Agonists; Disease Models, Animal; Dopamine Antagonists; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Transgenic; Nitric Oxide Synthase; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists | 2001 |
1 trial(s) available for risperidone and mdl 100907
| Article | Year |
|---|---|
Risperidone diminishes cocaine-induced craving.
Topics: Adult; Antipsychotic Agents; Cocaine-Related Disorders; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Motivation; Premedication; Risperidone; Serotonin 5-HT2 Receptor Antagonists; Substance Abuse, Intravenous | 2005 |
28 other study(ies) available for risperidone and mdl 100907
| Article | Year |
|---|---|
2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
Topics: Animals; Azepines; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Humans; Mice; Molecular Structure; NIH 3T3 Cells; Pyrimidines; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Structure-Activity Relationship | 2008 |
Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
Topics: Binding Sites; Ether-A-Go-Go Potassium Channels; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Potassium Channel Blockers; Protein Binding; Protein Conformation | 2009 |
Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone.
Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Fluorobenzenes; Isoxazoles; Male; Motor Activity; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Risperidone; Serotonin Antagonists | 1994 |
Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol.
Topics: Amphetamines; Animals; Antipsychotic Agents; Clozapine; Conditioning, Operant; Fluorobenzenes; Haloperidol; Male; Piperidines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Reinforcement, Psychology; Risperidone; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
Topics: Animals; Antipsychotic Agents; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluorobenzenes; Male; Piperidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Reflex, Startle; Risperidone; Serotonin Antagonists; Species Specificity | 1999 |
Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
Topics: 3T3 Cells; Animals; Antipsychotic Agents; Benzodiazepines; Cell Line; Clozapine; Dendrites; Fluorobenzenes; Haloperidol; Mianserin; Mice; Olanzapine; Piperidines; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recombinant Proteins; Risperidone; Ritanserin; Serotonin Antagonists; Transfection | 1999 |
The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Dopamine; Fluorobenzenes; Haloperidol; Male; Microdialysis; Nucleus Accumbens; Piperazines; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium | 2000 |
A behavioural pattern analysis of hypoglutamatergic mice--effects of four different antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Dizocilpine Maleate; Dopamine Antagonists; Drug Combinations; Excitatory Amino Acid Antagonists; Fluorobenzenes; Glutamic Acid; Haloperidol; Injections, Intraperitoneal; Male; Mice; Motor Activity; Piperidines; Risperidone; Serotonin Antagonists | 2001 |
Risperidone reduces limited access alcohol drinking in alcohol-preferring rats.
Topics: Alcohol Drinking; Alcoholism; Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; Rats; Risperidone; Saccharin; Self Administration; Serotonin 5-HT2 Receptor Antagonists | 2003 |
Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.
Topics: Adult; Antipsychotic Agents; Catechol O-Methyltransferase; Chi-Square Distribution; Dopamine D2 Receptor Antagonists; Female; Humans; Male; Middle Aged; Polymorphism, Genetic; Psychotic Disorders; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Statistics, Nonparametric | 2003 |
Reply to "Risperidone-induced obsessive-compulsive symptoms: serotonin-dopamine imbalance?".
Topics: Antipsychotic Agents; Brain; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Long-Term Care; Obsessive-Compulsive Disorder; Risk Factors; Risperidone; Serotonin; Serotonin 5-HT2 Receptor Antagonists | 2004 |
An efficient synthesis of risperidone via stille reaction: antipsychotic, 5-HT2, and dopamine-D2-antagonist.
Topics: Antipsychotic Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Risperidone; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2005 |
Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone.
Topics: Adult; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Piperazines; Risperidone; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Thiazoles | 2007 |
Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered.
Topics: Animals; Behavior, Animal; Clozapine; Conditioning, Psychological; Cycloserine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Emotions; Fluorobenzenes; Glycine; Glycine Agents; Inhibition, Psychological; Male; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Stress, Psychological; Thirst; Treatment Outcome | 2008 |
Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Dopamine; Dopamine D2 Receptor Antagonists; Drug Synergism; Extracellular Space; Fluorobenzenes; Glutamic Acid; Haloperidol; Imidazoles; Indoles; Male; Microdialysis; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin 5-HT2 Receptor Antagonists | 2009 |
Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats.
Topics: Age Factors; Animals; Animals, Newborn; Brain; Dose-Response Relationship, Drug; Male; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Risperidone; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2010 |
Hippocampal serotonin depletion facilitates the enhancement of prepulse inhibition by risperidone: possible role of 5-HT(2C) receptors in the dorsal hippocampus.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Ergolines; Hippocampus; Male; Nerve Tissue Proteins; Neural Inhibition; Neurons; Organ Specificity; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Reflex, Startle; Risperidone; Schizophrenia; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2011 |
Tolerability and safety profile of risperidone in a sample of children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Body Composition; Body Mass Index; Child; Child Development Disorders, Pervasive; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Antagonists; Drug Monitoring; Female; Follow-Up Studies; Humans; Male; Prolactin; Risperidone; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Tic Disorders; Up-Regulation; Weight Gain | 2013 |
Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Data Interpretation, Statistical; Dizocilpine Maleate; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fluorobenzenes; Haloperidol; Male; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reflex, Startle; Risperidone; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sulfonamides; Thiophenes | 2014 |
Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice.
Topics: Animals; Antipsychotic Agents; Autistic Disorder; Disease Models, Animal; Fluorobenzenes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Piperidines; Probability Learning; Receptor, Serotonin, 5-HT2A; Reversal Learning; Risperidone; Serotonin 5-HT2 Receptor Antagonists | 2014 |
Nest building is impaired in the Ts65Dn mouse model of Down syndrome and rescued by blocking 5HT2a receptors.
Topics: Animals; Cognition Disorders; Disease Models, Animal; Down Syndrome; Gene Expression; Mice; Nesting Behavior; Phenotype; Receptor, Serotonin, 5-HT2A; Risperidone; Serotonin 5-HT2 Receptor Antagonists | 2014 |
Activation of 5-HT2A/C receptor reduces glycine receptor-mediated currents in cultured auditory cortical neurons.
Topics: Amphetamines; Animals; Auditory Cortex; Cells, Cultured; GTP-Binding Proteins; Guanosine Diphosphate; Ion Channels; Microtubules; Neurons; Nocodazole; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Glycine; Risperidone; Ritanserin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Strychnine; Thionucleotides; Tubulin Modulators | 2016 |
Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists.
Topics: Animals; Barium; Calcium; G Protein-Coupled Inwardly-Rectifying Potassium Channels; HEK293 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Ketanserin; Membrane Potentials; Mutation; Oocytes; Protein Binding; Receptor, Serotonin, 5-HT2A; Risperidone; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Tritium; Xenopus laevis | 2016 |
Preparation and in vivo evaluation of a gel-based nasal delivery system for risperidone.
Topics: Administration, Intranasal; Animals; Antipsychotic Agents; Anura; Biological Availability; Cilia; Dopamine D2 Receptor Antagonists; Drug Compounding; Drug Delivery Systems; Gels; In Vitro Techniques; Male; Mouth Mucosa; Nasal Absorption; Nasal Mucosa; Palate; Random Allocation; Rats, Wistar; Risperidone; Serotonin 5-HT2 Receptor Antagonists | 2016 |
Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Dopamine D2 Receptor Antagonists; Humans; Male; Mice, Inbred ICR; Microsomes, Liver; Molecular Structure; Picolinic Acids; Risperidone; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship | 2018 |
Serotonin 5-HT
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antipsychotic Agents; Brain Waves; Cortical Synchronization; Dopamine Agonists; Dopamine Antagonists; Electroencephalography; Fluorobenzenes; Gamma Rhythm; Haloperidol; Hippocampus; Locomotion; Mice; Neural Pathways; Piperazines; Piperidines; Prefrontal Cortex; Pyridines; Quinpirole; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone; Serotonin Antagonists; Serotonin Receptor Agonists | 2019 |
Risperidone and 5-HT2A Receptor Antagonists Attenuate and Reverse Cocaine-Induced Hyperthermia in Rats.
Topics: Animals; Benzazepines; Cocaine; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Hyperthermia; Ketanserin; Male; Rats; Rats, Wistar; Risperidone; Ritanserin; Serotonin 5-HT2 Receptor Antagonists | 2020 |
Serotonin 2A (5-HT
Topics: Amphetamines; Animals; Antipsychotic Agents; Cell-Matrix Junctions; Chlorpromazine; HEK293 Cells; Humans; Mental Disorders; Olanzapine; Rats; Receptor, Serotonin, 5-HT2A; Risperidone; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Stress Fibers | 2020 |